Deanna L. Kelly PharmD, BCPP

Deanna L. Kelly, Pharm.D., BCPP is a Professor of Psychiatry at the University of Maryland Baltimore School of Medicine and an Affiliate Professor in the School of Pharmacy. She is currently Director and Chief of the Treatment Research Program at the Maryland Psychiatric Research Center (MPRC).

Dr. Kelly received her Bachelor of Science and Doctorate in Pharmacy at Duquesne University in Pittsburgh, PA. She completed residency training in psychiatric pharmacy practice at the University of Maryland in 1997 and became board certified in psychiatric pharmacy practice in 1998.

Dr. Kelly has led and been involved in numerous clinical trials in schizophrenia and severe mental illness and has been active in psychopharmacology research for the past 23 years.

Dr. Kelly has co-authored and authored 19 books and book chapters, published over 200 peer-reviewed articles, presented over 250 scientific posters, and has given over 175 invited lectures. She has co-authored four editions of the book entitled “Pharmacologic Treatment of Schizophrenia.” She also authors the Schizophrenia chapter for “Pharmacotherapy, Principles, and Practice.”

She is Past President for the College of Psychiatric & Neurologic Pharmacists (CPNP), a Fellow of the American College of Neuropsychopharmacology (ACNP), currently serves as a clozapine content expert for the American Psychiatric Association SMI Adviser, and is a champion of clozapine use, women's health issues, inflammation and immune dysfunction in schizophrenia and for finding new treatments.